Finance

Lists
Why is CHRS down 8,04%?
Dive Deeper
CHRS:NASDAQ
Coherus Oncology Inc
US$1,03
-8,04%
(-0,090) 1D
US$1,04
+1,42% (+0,015)
After hours
Closed: 6 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CHRS...
Open
US$1,13
High
US$1,13
Low
US$1,01
Mkt. cap
164,82 ລ້ານ
Avg. vol.
1,25 ລ້ານ
Volume
2,97 ລ້ານ
52-wk high
US$2,62
52-wk low
US$1,01
EPS
US$-1,03
Beta
0,98
Shares outstanding
154,50 ລ້ານ
No. of employees
144
Open
US$1,13
High
US$1,13
Low
US$1,01
Mkt. cap
164,82 ລ້ານ
Avg. vol.
1,25 ລ້ານ
Volume
2,97 ລ້ານ
52-wk high
US$2,62
52-wk low
US$1,01
EPS
US$-1,03
Beta
0,98
Shares outstanding
154,50 ລ້ານ
No. of employees
144
News stories
From web sources and news partners
About Coherus Oncology Inc
CEODennis Lanfear
Employees144
Founded2010
HeadquartersRedwood City, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorBiotechnology
Websitecoherus.com
Analyst ratings
Based on 4 analysts giving stock ratings to CHRS in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CHRS in the last 3 months.
Highest
Current US$1,03
US$10,00 (+870,87%)
Average
US$7,75 (+652,43%)
Lowest
US$4,00 (+288,35%)
Analyst
Recommendation
Action
Price target
Projected
Date
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
US$7,00
+579,6%
09/21/2026
Jason McCarthy
Maxim Group
Buy
Maintained
US$4,00
+288,3%
08/06/2026
Paul Jeng
Guggenheim
Buy
Maintained
US$10,00
+870,9%
08/06/2026
Jay Olson
Oppenheimer
Buy
Maintained
US$10,00
+870,9%
08/06/2026
Michael Nedelcovych
TD Cowen
Buy
Maintained
-
-
05/28/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
11,57 ລ້ານ
12,75 ລ້ານ
12,31 ລ້ານ
14,31 ລ້ານ
Cost of goods sold
3,72 ລ້ານ
4,04 ລ້ານ
3,81 ລ້ານ
4,24 ລ້ານ
Cost of revenue
3,72 ລ້ານ
4,04 ລ້ານ
3,81 ລ້ານ
4,24 ລ້ານ
Research and development expenses
27,25 ລ້ານ
30,97 ລ້ານ
21,54 ລ້ານ
21,45 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22,83 ລ້ານ
21,01 ລ້ານ
23,10 ລ້ານ
20,95 ລ້ານ
Operating expense
50,08 ລ້ານ
51,98 ລ້ານ
44,65 ລ້ານ
42,40 ລ້ານ
Total operating expenses
53,80 ລ້ານ
56,03 ລ້ານ
48,46 ລ້ານ
46,64 ລ້ານ
Operating income
-42,23 ລ້ານ
-43,28 ລ້ານ
-36,15 ລ້ານ
-32,33 ລ້ານ
Other non operating income
2,14 ລ້ານ
-5,22 ລ້ານ
1,40 ລ້ານ
1,31 ລ້ານ
EBT including unusual items
-44,52 ລ້ານ
-46,35 ລ້ານ
-36,94 ລ້ານ
-33,35 ລ້ານ
EBT excluding unusual items
-42,42 ລ້ານ
-43,75 ລ້ານ
-36,94 ລ້ານ
-33,35 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-35,53 ລ້ານ
-37,64 ລ້ານ
-38,33 ລ້ານ
-20,63 ລ້ານ
Net profit margin
-307,07%
-295,29%
-311,35%
-144,20%
Earnings per share
-0,33
-0,34
-0,25
-0,19
Interest and investment income
-
7,00 ລ້ານ
-
-
Interest expense
-2,32 ລ້ານ
-2,25 ລ້ານ
-2,19 ລ້ານ
-2,32 ລ້ານ
Net interest expenses
-2,32 ລ້ານ
4,75 ລ້ານ
-2,19 ລ້ານ
-2,32 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-41,27 ລ້ານ
-42,38 ລ້ານ
-35,27 ລ້ານ
-31,47 ລ້ານ
Gain or loss from assets sale
-
-338,32 ລ້ານ
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
ແອັບຂອງ Google